How a TEDCO portfolio company, Adaptive Phage Therapeutics, is saving lives with bacteria-killing viruses
Source: External source
Dr. Carl Merril began researching bacteria-killing viruses at National Institutes of Health in 1965, leading to a partnership with the U.S. Navy’s biological defense group to combat potential bioterrorism attacks with superbugs.
Posted July 10, 2018
About TEDCO
TEDCO, the Maryland Technology Development Corporation, enhances economic empowerment growth through the fostering of an inclusive entrepreneurial innovation ecosystem. TEDCO identifies, invests in, and helps grow technology and life science-based companies in Maryland. Learn more at www.tedcomd.com.
Media Contacts
Tammi Thomas, President, TEDCO, tthomas@tedcomd.com
Rachael Kalinyak, Associate Director, Marketing & Communications, TEDCO, rkalinyak@tedcomd.com